Neion Bio
Neion Bio lands $23M Series A to make proteins from chicken eggs
200 million years of evolution. Frontier genetic engineering. Tomorrow’s medicines.
We are building the biomanufacturing platform of the future, using evolution's best molecular factories.
Mission
We harness nature’s best protein factories to make medicine affordable, accessible, and resilient.
We envision a world in which producing the medicines in our hospitals is as easy and affordable as producing the food in our grocery stores.
Evolution has created wonders of engineering – autonomous, self-replicating 3D printers – capable of converting simple inputs, like grain and water, into complex outputs, like eggs and silk. What if we could re-engineer those systems to produce life-saving medicines?
Nature's best protein factories, re-engineered.
Technology
The Raptor ™ platform
We build living bioreactors to manufacture any biomolecule at scale – powered by next-generation genetic engineering and stem cell biology.
We scale out rather than scale up
Using this evolutionarily optimized, easily replicable vessel, we manufacture recombinant therapeutics in a highly reliable manner, eliminating the risk of scale up.
Platform Technology
Raptor Line V2.5
Process
How We Scale
- Genetic Sequence ID: 6912048-026912048-02
- Recombinant Protein Type: Peptide
- Expression Status: Active
- Batch Size: 25,000 Eggs
- Batch Composition Variability: <2%
- Production Window: 4 Weeks
Our Raptor™ platform is:
- Extremely Low COGS: Up to 10x lower COGS
- Hyper Resilient: Localizable inputs for onshore manufacturing
- CapEx Avoidant: Up to 100x lower CapEx
- Ultra Scalable: Near zero scale-up risk to any volume
- Very High Reliability: Ultra low batch-to-batch variability
- Lower Environmental Impact: 10-100x lower carbon footprint
We partner with
- biosimilars
- biotech
- animal health
- reagents
We solve critical challenges for our partners
Traditional biomanufacturing is expensive, slow to scale, highly variable from batch to batch, and vulnerable to supply chain shocks.
Neion Bio is trusted by some of the most important companies in biopharma to solve these problems, unlocking portfolio optionality and huge economic value. We develop and manufacture lower cost, higher consistency biological molecules including: monoclonal antibodies, enzymes, fusion proteins, peptides, cytokines, and other biologics.
We manufacture for therapeutic or non-therapeutic use, at any scale, with site flexibility and rapid ramp-up.
Partner with Us
Biosimilars
Access capabilities and capacity with minimal investment while preserving cost leadership.
Biotech
Develop difficult-to-express proteins, and secure long-term supply through flexible and scalable production.
Animal Health
Innovate while maintaining low COGS in a cash-pay market.
Reagents
Replace outdated infrastructure with reliable, consistent supply.
We manufacture
- Monoclonal antibodies
- Multi-specifics
- Enzymes
- Cytokines
- Fusion proteins
- Peptides
- Therapeutic proteins
- Therapeutic reagents
Careers
Come and work at the cutting edge of genome engineering, stem cell biology, and protein science. We are reinventing the infrastructure of modern medicine, democratizing access to life-saving therapeutics.